Nath Bio-Genes (India) Statistics

Total Valuation

NSE:NATHBIOGEN has a market cap or net worth of INR 3.94 billion. The enterprise value is 4.28 billion.

Market Cap	3.94B
Enterprise Value	4.28B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	Aug 9, 2024

Share Statistics

NSE:NATHBIOGEN has 19.00 million shares outstanding. The number of shares has increased by 0.85% in one year.

Current Share Class	19.00M
Shares Outstanding	19.00M
Shares Change (YoY)	+0.85%
Shares Change (QoQ)	-34.81%
Owned by Insiders (%)	9.52%
Owned by Institutions (%)	3.20%
Float	6.36M

Valuation Ratios

The trailing PE ratio is 10.44.

PE Ratio	10.44
Forward PE	n/a
PS Ratio	1.08
PB Ratio	0.61
P/TBV Ratio	0.62
P/FCF Ratio	40.78
P/OCF Ratio	22.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.59, with an EV/FCF ratio of 44.25.

EV / Earnings	11.08
EV / Sales	1.17
EV / EBITDA	8.59
EV / EBIT	9.30
EV / FCF	44.25

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.19.

Current Ratio	1.89
Quick Ratio	0.50
Debt / Equity	0.19
Debt / EBITDA	2.46
Debt / FCF	12.68
Interest Coverage	4.39

Financial Efficiency

Return on equity (ROE) is 6.07% and return on invested capital (ROIC) is 3.86%.

Return on Equity (ROE)	6.07%
Return on Assets (ROA)	3.01%
Return on Invested Capital (ROIC)	3.86%
Return on Capital Employed (ROCE)	6.96%
Revenue Per Employee	8.63M
Profits Per Employee	912,525
Employee Count	423
Asset Turnover	0.38
Inventory Turnover	0.48

Taxes

In the past 12 months, NSE:NATHBIOGEN has paid 19.85 million in taxes.

Income Tax	19.85M
Effective Tax Rate	4.96%

Stock Price Statistics

The stock price has decreased by -2.26% in the last 52 weeks. The beta is 0.44, so NSE:NATHBIOGEN's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-2.26%
50-Day Moving Average	184.88
200-Day Moving Average	182.21
Relative Strength Index (RSI)	62.25
Average Volume (20 Days)	43,606

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NATHBIOGEN had revenue of INR 3.65 billion and earned 386.00 million in profits. Earnings per share was 20.14.

Revenue	3.65B
Gross Profit	2.29B
Operating Income	459.82M
Pretax Income	400.44M
Net Income	386.00M
EBITDA	497.98M
EBIT	459.82M
Earnings Per Share (EPS)	20.14

Full Income Statement

Balance Sheet

The company has 888.99 million in cash and 1.23 billion in debt, giving a net cash position of -336.01 million or -17.68 per share.

Cash & Cash Equivalents	888.99M
Total Debt	1.23B
Net Cash	-336.01M
Net Cash Per Share	-17.68
Equity (Book Value)	6.44B
Book Value Per Share	496.02
Working Capital	3.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 175.81 million and capital expenditures -79.20 million, giving a free cash flow of 96.61 million.

Operating Cash Flow	175.81M
Capital Expenditures	-79.20M
Free Cash Flow	96.61M
FCF Per Share	5.08

Full Cash Flow Statement

Margins

Gross margin is 62.85%, with operating and profit margins of 12.60% and 10.58%.

Gross Margin	62.85%
Operating Margin	12.60%
Pretax Margin	10.97%
Profit Margin	10.58%
EBITDA Margin	13.65%
EBIT Margin	12.60%
FCF Margin	2.65%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.96%.

Dividend Per Share	2.00
Dividend Yield	0.96%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	9.85%
Buyback Yield	-0.85%
Shareholder Yield	0.12%
Earnings Yield	9.80%
FCF Yield	2.45%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3